NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Follicular Lymphoma

Interventions: Obinutuzumab

Countries: Italy

To evaluate the effectiveness and safety of obinutuzumab in clinical routine in 1L FL measured by the % of relapse within 24 months from start of therapy.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Signed Informed consent according to local regulations, after performing at least 2 cycles of induction treatment with Obinutuzumab and chemotherapy, within 1 year from beginning of treatment

Exclusion Criteria:

* Any contraindications to Obinutuzumab therapy according to local label for specific indication;
* Concomitant participation in an interventional clinical study;
* Participants not receiving treatment for untreated follicular lymphoma with Obinutuzumab according to standard of care and in line with local labeling.

Locations (46)

Pescara, Abruzzo, Italy
Bari, Apulia, Italy
Bari, Apulia, Italy
Barletta, Apulia, Italy
Lecce, Apulia, Italy
San Giovanni Rotondo (FG), Apulia, Italy
Tricase - LE, Apulia, Italy
Reggio Calabria, Calabria, Italy
Avellino, Campania, Italy
Caserta, Campania, Italy
Naples, Campania, Italy
Naples, Campania, Italy
Pagani (Sa), Campania, Italy
Bologna, Emilia-Romagna, Italy
Modena, Emilia-Romagna, Italy
Reggio Emilia, Emilia-Romagna, Italy
Aviano, Friuli Venezia Giulia, Italy
Udine, Friuli Venezia Giulia, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Bergamo, Lombardy, Italy
Milan, Lombardy, Italy
Milan, Lombardy, Italy
Milano Policlinico Maggiore, Lombardy, Italy
Pavia, Lombardy, Italy
Varese, Lombardy, Italy
Alessandria, Piedmont, Italy
Turin, Piedmont, Italy
+ 16 more on CT.gov